These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1813658)
1. Recombinant human erythropoietin, but not iron supplementation, improves anemia in rats with adjuvant-induced arthritis. Asai F; Oshima T Jpn J Pharmacol; 1991 Nov; 57(3):291-8. PubMed ID: 1813658 [TBL] [Abstract][Full Text] [Related]
2. Reduced erythrocyte deformability in anemic rats with adjuvant arthritis. Asai F; Oshima T Jpn J Pharmacol; 1990 Aug; 53(4):510-4. PubMed ID: 2214374 [TBL] [Abstract][Full Text] [Related]
3. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management. Van Wyck DB Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082 [TBL] [Abstract][Full Text] [Related]
4. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159 [TBL] [Abstract][Full Text] [Related]
5. Iron management during recombinant human erythropoietin therapy. Van Wyck DB Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):9-13. PubMed ID: 2757026 [TBL] [Abstract][Full Text] [Related]
6. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel. Yagil Y Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516 [TBL] [Abstract][Full Text] [Related]
7. Serum erythropoietin levels in elderly inpatients with anemia of chronic disorders and iron deficiency anemia. Joosten E; Van Hove L; Lesaffre E; Goossens W; Dereymaeker L; Van Goethem G; Pelemans W J Am Geriatr Soc; 1993 Dec; 41(12):1301-4. PubMed ID: 8227911 [TBL] [Abstract][Full Text] [Related]
8. Iron and erythropoietin measurement in autologous blood donors with anemia: implications for management. Tasaki T; Ohto H; Noguchi M; Motoki R; Kikuchi S; Sato A; Hoshino S Transfusion; 1994 Apr; 34(4):337-43. PubMed ID: 8178331 [TBL] [Abstract][Full Text] [Related]
9. Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats. Sartor RB; Anderle SK; Rifai N; Goo DA; Cromartie WJ; Schwab JH Infect Immun; 1989 Apr; 57(4):1177-85. PubMed ID: 2784417 [TBL] [Abstract][Full Text] [Related]
10. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia. Sakata S; Iwami K; Enoki Y; Kohzuki H; Shimizu S; Matsuda M; Moriyama T Exp Hematol; 1988 Aug; 16(7):581-7. PubMed ID: 3391251 [TBL] [Abstract][Full Text] [Related]
11. Case management of the anemic patient: epoetin alfa--focus on iron supplementation. Kirlin LF ANNA J; 1993 Dec; 20(6):678-81. PubMed ID: 8267412 [TBL] [Abstract][Full Text] [Related]
12. The effect of treatment with recombinant human erythropoietin on skeletal muscle function in patients with end-stage renal failure treated with regular hospital hemodialysis. Davenport A Am J Kidney Dis; 1993 Nov; 22(5):685-90. PubMed ID: 8238014 [TBL] [Abstract][Full Text] [Related]
13. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia. Landau D; London L; Bandach I; Segev Y PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538 [TBL] [Abstract][Full Text] [Related]
14. [Theory on the pathogenesis of anemia in the course of adjuvant arthritis]. MikoĊajew-Czaplarska MA Reumatologia; 1979; 17(2):203-6. PubMed ID: 472530 [No Abstract] [Full Text] [Related]
15. Serum erythropoietin (EST) titers in anemia. de Klerk G; Rosengarten PC; Vet RJ; Goudsmit R Blood; 1981 Dec; 58(6):1164-70. PubMed ID: 7306704 [TBL] [Abstract][Full Text] [Related]
16. Delayed erythropoiesis in irradiated rats grafted with syngeneic marrow: effects of cytotoxic drugs and iron-deficiency anemia. Rodday P; Bennett M; Vitale JJ Blood; 1976 Sep; 48(3):435-47. PubMed ID: 782611 [TBL] [Abstract][Full Text] [Related]
17. Decreased erythropoietin responsiveness to iron deficiency anemia in the elderly. Nafziger J; Pailla K; Luciani L; Andreux JP; Saint-Jean O; Casadevall N Am J Hematol; 1993 Jul; 43(3):172-6. PubMed ID: 8352231 [TBL] [Abstract][Full Text] [Related]
18. The effects of recombinant human erythropoietin on mean corpuscular volume in patients with the anemia of chronic renal failure. Schwartz AB; Orquiza CS Clin Nephrol; 1995 Apr; 43(4):256-9. PubMed ID: 7606880 [TBL] [Abstract][Full Text] [Related]
19. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan. Akizawa T; Koshikawa S; Takaku F; Urabe A; Akiyama N; Mimura N; Otsubo O; Nihei H; Suzuki Y; Kawaguchi Y Int J Artif Organs; 1988 Sep; 11(5):343-50. PubMed ID: 3056862 [TBL] [Abstract][Full Text] [Related]
20. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. Takashina N; Kondo H; Kashiwazaki S J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]